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ABSTRACT 
Suicide is a major cause of death worldwide, responsible for 1.5% of all mortality. The causes of 
suicidal behavior are not fully understood. Dysregulated hypothalamic-pituitary-adrenal (HPA) axis 
activity, as measured by cortisol levels, is one potential risk factor. This meta-analytic review aimed i) 
to estimate the strength and variability of the association between naturally fluctuating cortisol levels 
and suicidal behavior and ii) to identify moderators of this relationship. A systematic literature search 
identified 27 studies (N = 2226; 779 suicide attempters & 1447 non-attempters) that met the study 
eligibility criteria from a total of 417 unique records initially examined. Estimates of effect sizes (r) 
obtained from these studies were analysed using Comprehensive Meta-Analysis. In these analyses, we 
compared participants identified as having a past history of suicide attempt(s) to those with no such 
history. Study quality, mean age of sample and percentage of male participants were examined as 
potential moderators. Overall, there was no significant effect of suicide group on cortisol. However, 
significant associations between cortisol and suicide attempts were observed as a function of age. In 
studies where the mean age of the sample was below 40 years the association was positive (i.e., higher 
cortisol was associated with suicide attempts; r = .234, p < .001), and where the mean age was 40 or 
above the association was negative (i.e., lower cortisol was associated with suicide attempts; r = - 
.129, p < .001). These findings confirm that HPA axis activity, as indicated by age-dependent 
variations in cortisol levels, is associated with suicidal behavior. The challenge for theory and clinical 
practice is to explain the complete reversal of the association with age and to identify its clinical 
implications.  
 
Funding: US Department of Defense (US DOD W81XWH-12-1-0007) 
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1. INTRODUCTION 
Suicide is a major cause of death worldwide, responsible for 1.5% of all mortality. The causes 
of suicidal behavior are not fully understood; however, this behavior clearly results from a complex 
interplay between many different factors. Numerous models have been proposed that differ in their 
emphasis on the role of psychological, social, psychiatric and neurobiological factors in predicting 
risk of suicide and identifying targets for intervention to improve suicide prevention (Mann et al., 
1999; O’Connor, 2011; O’Connor & Nock, 2014; van Heeringen and Mann, 2014; van Orden et al., 
2010). However, central to many models is a stress-diathesis component which states that suicidal 
behavior is a result of an interaction between acutely stressful events and a susceptibility to suicidal 
behavior (a diathesis).  Evidence is accumulating from post-mortem, neuroimaging and in-vivo 
studies that a trait diathesis is not only manifested in impairments of the serotonergic and 
noradrenergic neurotransmitter systems, in structural brain abnormalities and via epigenetic pathways 
but also in dysregulation of hypothalamic-pituitary-adrenal (HPA) axis stress response activity 
(Mann, 2013; Turecki et al., 2012; van Heeringen et al., 2011; van Heeringen and Mann, 2014).
 
Moreover, it has been suggested that biomarkers of a trait-diathesis following serious stressful and 
traumatic psychosocial events, independent of psychiatric co-morbidities, may be useful predictors of 
suicide risk (van Heeringen and Mann, 2014). One such potential biomarker is the glucocorticoid, 
cortisol. 
 When we experience stress, the HPA axis is activated and releases cortisol from the adrenal 
glands. Once released, cortisol has several important functions such as increasing access to energy 
stores, increasing protein and fat mobilisation, as well as regulating the magnitude and duration of 
inflammatory responses (Sapolsky et al., 2000). Cortisol has also been found to be associated with 
impairments in cognitive control, decision-making and emotional processing linked to suicidal 
behavior (Giletta et al., 2015; Turecki et al., 2012). As such, cortisol is the primary effector hormone 
of the HPA axis stress response system and has received extensive empirical investigation. As with 
other aspects of the endocrine system, the HPA axis is regulated by a negative feedback system, 
whereby the hypothalamus and the pituitary gland have receptors that detect changes in cortisol 
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levels. For example, cortisol secretion will be inhibited when circulating levels rise or it will be 
stimulated when levels fall. However, if the HPA axis is repeatedly activated, this will trigger 
increased cortisol output, thereby exposing bodily tissues to excessive concentrations of the hormone 
(McEwen, 1998; McEwen, 2000; Miller et al., 2007). Over time, such repetitive activation may lead 
to tissue damage and contribute to future ill health by placing excessive pressure on various bodily 
systems including the HPA axis (known as allostatic load; McEwen, 1998). Nonetheless, the precise 
effects of psychological stress on HPA axis regulation in relation to the diurnal cortisol profile and 
how this relates to suicidal behavior remains unclear.  
The majority of previous research on cortisol and suicidal behavior relations has focused on 
assessing HPA axis functioning through pharmacological manipulation of the stress system (Mann 
and Currier, 2007; Pompili et al., 2010). The Dexamethasone Suppression Test (DST; Carroll et al., 
1968)
 
has been commonly employed to assess HPA axis dysregulation by measuring cortisol 
inhibition after the administration of the synthetic glucocorticoid Dexamethasone. Failure to suppress 
cortisol is evidence for HPA-axis hyperactivity and has consistently been found to predict completed 
suicide in patients with mood disorder for example (Coryell and Schlesser, 1981; Coryell et al., 2006; 
Jokinen and Nordstrom, 2008; Jokinen and Nordstrom, 2009; Jokinen et al., 2009; Norman et al., 
1990). However, whilst DST research has contributed enormously to knowledge regarding HPA axis 
dysregulation and suicide vulnerability, findings remain inconsistent and contradictory (McGirr et al., 
2011). Pharmacological manipulation has also been criticised as it may not adequately mimic the size 
of the endogenous HPA response to naturally occurring stressors (Burke et al., 2005). In addition, 
more recent studies have begun to explore other aspects of the cortisol response, such as the diurnal 
cortisol rhythm (including morning and afternoon/evening cortisol levels) and cortisol reactivity to 
stressors (for example, see McGirr et al., 2010). 
 Studies that have explored the relationship between naturally fluctuating cortisol and suicidal 
behavior have yielded inconsistent findings. For example, Westrin et al. (1999) found elevated 
cortisol levels in patients who had recently attempted suicide compared to healthy controls, while 
Lindqvist and colleagues (2008) found that cortisol levels were significantly lower in suicide 
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attempters compared to controls. A number of methodological factors may account for these mixed 
findings including the timing of the cortisol sampling (morning vs afternoon/evening) and study 
quality (both of which are examined in the current meta-analysis). However, age is another important 
variable that has been found to be associated with cortisol levels and suicidal behavior (Hawton et al., 
2012; Hawton and van Heeringen, 2009). For example, cortisol levels have been shown to increase as 
part of normal aging (possibly mediated by diminished negative feedback inhibition), but normal-to-
low levels of cortisol have also been observed in older Holocaust survivors with posttraumatic stress 
disorder (PTSD) and in patient groups with different stress-related disorders such as fibromyalgia 
(Ferrari et al., 2000; Fries et al., 2005; Yehuda et al., 2005). Taken together, these data suggest that 
the relationship between age and cortisol levels is far from straightforward and it is likely moderated 
by stress-related factors. In terms of suicidal behavior, age has been found to be differentially 
associated with suicide. In most regions in the world, suicide rates are highest in individuals aged 70 
years and older (World Health Organization, 2014). However, in some countries, the highest levels of 
suicide are among the young (15-29 year olds) and in more wealthy countries, men are three times as 
likely to die by suicide. However, it is worth noting that age has also been found to be inversely 
associated with suicide attempt, such that greater levels of suicide attempt have been observed in 
younger people (e.g., Nock et al., 2008). Therefore, for these reasons, the mean age of the sample and 
percentage of males in each sample will be also explored as potential moderators of the relationship 
between cortisol and suicide attempter status (Hawton et al., 2012; Hawton and van Heeringen, 2009). 
Therefore, the goal of this review was to synthesize findings from all existing research that has 
compared participants with at least one prior suicide attempt with a comparison group with no suicide 
attempt history in order: i) to estimate the strength and variability of the association between naturally 
fluctuating cortisol levels and suicidal behavior and ii) to identify moderators of this relationship.  
2. METHOD 
2.1. Search Strategy 
PubMed, ISI Web of Science (ISI WOS) and PsycINFO were searched for full published 
reports from 1958 until the end of February 2015. The following search terms were used; (i) suicid* 
AND cortisol. Initially all abstracts were examined to identify studies meeting the study inclusion 
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criteria, before the full text was assessed for eligibility. The search strategy was inclusive, including 
studies of inpatient, outpatient and non-clinical samples.  
The following eligibility criteria were used: (1) published in a peer-reviewed journal and 
written in English, (2) levels of naturally occurring cortisol were reported, assayed from either 
cerebral spinal fluid, urine, saliva, or blood, (3) a measure or report of suicide attempt history was 
described, (4) the sample included a case group of participants who had made at least one prior 
suicide attempt and comparison participants with no history of suicide attempt, and (5) the association 
between cortisol and suicide history was reported, or a statement that an association did not exist was 
specified. Studies which only reported cortisol levels after the introduction of an exogenous substance 
(e.g. dexamethasone) were excluded. Studies which carried out a challenge test but reported pre-
manipulation cortisol levels were included, but only those findings relating to cortisol measured prior 
to manipulation were used.   
2.2. Data Extraction 
 The following information was taken from each published report: the study design, sample 
demographic information and any exclusion criteria, the primary sample diagnoses and method used 
to assess psychopathology, the methodology used to ascertain suicide history, procedural details 
relating to the assessment of cortisol, controlled variables, details relating to longitudinal designs 
(duration, follow up procedure, attrition rate) and the main findings or related statistical information 
between cortisol and suicide group.   
2.3. Quality Assessment 
 Each study was assessed for methodological quality using a six item index developed a priori 
by the authors.  A score from 0-2 (with the exception of suicide attempt history assessment scored 0-
3) was given for each item, and then a total quality score was calculated ranging from a score of 0 to a 
maximum of 13. The six methodological criteria points can be found in Table 1 in the Supplementary 
Materials. 
2.4. Statistical Analysis 
We compared participants identified as having a past history of suicide attempt(s) to 
individuals with no such history. If multiple case groups existed within these categories (e.g. violent 
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and non-violent attempters), an average value was used. Due to the majority of studies assaying 
cortisol from blood, if within studies there were multiple analytical methods (e.g. blood and urine 
samples), only blood data was included in the analyses in order to not “double count” any one study. 
However, in those studies where cortisol was only sampled from non-blood substances (e.g. saliva, 
cerebrospinal fluid) we extracted the available data. 
Data were available for cortisol at various time points. Although the majority of studies only 
sampled morning cortisol (before midday), we did not want to exclude data collected at different time 
points. Therefore, an overall analysis was conducted which included all data regardless of the time of 
day.  However, acknowledging the importance time of day has on cortisol levels, separate analyses 
were carried out only including cortisol samples collected before midday (AM) and cortisol collected 
in the afternoon or evening (PM).  
The correlation coefficient was used as the index of effect size for the reasons specified by 
Roberts et al., 2007). Other effect size estimates, such as odds ratios (OR) and risk ratios (RR), can 
make small effects appear bigger than they are in absolute terms. Second, compared to indices like 
ORs, the correlation has an upper and lower limit for judging the relative size of the effect.  
All analyses were conducted in Comprehensive Meta-Analysis (CMA) version 2©. All effects 
were coded to indicate if cortisol was higher in the suicide attempters versus the non-attempters, with 
random effects models estimated.  
3. RESULTS 
3.1. Study Information 
In total, 854 records were initially identified. After the removal of duplicates, the abstracts of 
491 unique records were examined (see Figure 1 in supplementary materials). The main reasons for 
excluding studies at this stage were that the subject matter did not relate to cortisol or suicidality, or 
the record was not a research article reporting primary data. Research studies measuring HPA 
functioning using pharmacological challenge tests (e.g. the DST) were retained at this stage if it could 
not be determined from the abstract alone whether they also measured pre-manipulation cortisol 
levels. After the exclusion of 365 records, the full texts of 126 articles were screened for eligibility. 
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Twenty-seven studies published between 1980 and 2013 were identified as meeting the inclusion 
criteria.   
3.2. Descriptive Statistics 
The characteristics of the 27 studies included in the meta-analysis are presented in Table 1. 
The combined sample totalled 2269 participants, including 798 suicide attempters and 1471 non-
attempters. The median sample size was 56 with a range of 22 to 359 participants.  The mean age in 
the individual studies ranged from 17.62 to 55.80 years, giving a combined mean age of 39.42 years 
(SD = 8.60). The average proportion in the combined sample reported as male was 50.1%. In terms of 
study quality, there was a broad range of scores allocated to studies extending from a low score of 2 to 
a high score of 11.  
Of the 24 studies that reported the specific time cortisol was assayed, 16 measured morning 
cortisol (66.6%), 4 only assayed during the afternoon or evening (16.6%) and four measured cortisol 
at multiple time points throughout the day (16.6%). The remaining three studies either did not report 
the time of day cortisol was assayed (Kim et al., 2013), or measured 24 hour cortisol from urine 
(Ostroff et al., 1982; van Heeringen et al., 2000).  
 3.3. Meta-analysis 
 The results of the random effects meta-analysis are shown in Table 2. Overall, no association 
was found between suicide group and cortisol for all 27 studies, the 24 studies that reported time of 
assay, or when analysing the AM and PM data separately (Table 2, upper panel).  However, there was 
a significant moderation effect for the mean age of the samples for all 27 studies and in each of the 
subgroup analyses (Table 2, upper panel). Meta-regression of r on age found a significant negative 
effect for age. At approximately 39-40 years there is a reversal of the direction of the effect size (see 
Figure 2 Supplementary Materials). Prior to 40 years the association is mostly positive (higher cortisol 
is associated with suicide attempts), whereas after 40 years this becomes generally negative (lower 
cortisol associated with suicide attempts). To examine this further we recoded average age into less 
than 40 years and equal to and greater than 40 years. We ran mixed effects models to examine 
whether there was a significant difference in the association between cortisol and suicide across this 
age split for all 27 studies, for the 24 studies that reported the specific time cortisol was assayed, and 
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then again separately in AM and PM samples. The results are shown in Table 2, lower panel. As can 
be seen in all cases, the differences are statistically significant, indicating that where the average age 
of the sample was below 40 years the association was positive, whereas it was negative for samples 
where the average age was equal to or above 40 years. A summary of the moderating effects of age 
are shown in the Forest Plot for the full sample (k = 27; Figure 3 in the Supplementary Materials). If 
we restrict these analyses just to blood samples the same pattern of results is observed (data not 
shown). It is also worth noting that the mean absolute levels of cortisol were consistent with the 
observed associations outlined above. In studies with a mean age less than 40 years, the mean cortisol 
was 399.19 nmol/L in the attempter group compared to 312.49 nmol/L in the non-attempter group. In 
studies with a mean age greater than 40 years, the mean cortisol was 367.10 nmol/L in the attempter 
group compared to 411.71 nmol/L in the non-attempter group.  
 There was no evidence that the association between suicide attempts and cortisol level was 
moderated by sex (Table 1, upper panel) or year of publication (data not shown). However, study 
quality was found to significantly influence the relationship. For the all (k = 27) analyses there was a 
significant effect of study quality (B = -0.03, p = .013) indicating that as quality improved the effect 
size becomes smaller. Similar results were found in the AM + PM (k = 24) analyses (B = -0.033, p = 
.007) and the AM only (k = 20) analyses (B = -0.05, p = .0005), but not for the PM only (k = 8) 
analyses (B = -0.02, p = .22).  
Nine studies were identified where the participants were diagnosed as having unipolar 
depression, major depressive disorder or depression (Ayuso-Gutiérrez and Cabranes, 1987; Brown et 
al., 1986; Brunner et al., 2002; Inder et al., 1997; Karlović et al., 2012; Kim et al., 2013; Pitchot et al., 
1995; 2005; Westrin et al., 1999). Therefore, we also explored whether the moderating effects of age 
was observable in this sub-group. Meta-regression showed a significant negative effect of age -0.013 
(p = .004) consistent with the analysis of the whole sample. Categorical moderation for age (average 
sample age below or above 40 years) demonstrated an effect approaching significant (Q = 3.34, p = 
.08), with a significant negative association between cortisol and suicide in samples older on average 
than 40 (r = -0.09, p = .018, k = 5) and a positive, but non-significant association, for samples under 
40 (r = 0.18, p = .238, k = 4). Thus the general pattern of results replicates the main findings.   
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3.4. Publication bias 
There was no evidence for publication bias (Table 1). Edger’s intercept was non-significant 
for all four analyses and Duvall and Tweedie’s Trim and Fill analysis indicated that there were no 
missing studies that would alter the result. However, Cochran’s Q was found to be significant for the 
overall analysis, and for the time subgroup analyses, suggesting considerable heterogeneity in study 
outcomes. The I
2 
statistic revealed that 79% to 83% of the variation in study outcomes was due to true 
heterogeneity, thereby confirming the need to examine the potential effects of moderating variables 
on the suicide attempts-cortisol association.  
3.5. Time between suicide attempt and assessment of cortisol 
One potential methodological confound is the time between the suicide-related event and the 
assessment of cortisol. We examined this by initially coding if temporal data were available or not and 
found that 14 of the 27 studies reported the timing of cortisol assessment. The association between 
cortisol and suicidal behavior did not vary systematically across reporting or not reporting temporal 
information (p = .17) and was non-significant in studies that did not report timing (p = .95) and those 
that did (p = .074). In addition, these temporal parameters (time recorded or not) did not influence the 
reversal in association around the 40 year age split, such that the observed effects remained in both 
groups but stronger in the group that did record temporal data. 
4. DISCUSSION 
The results of this meta-analysis confirm that HPA axis activity, as indicated by age-
dependent variations in naturally occurring cortisol levels, are associated with suicide attempt. 
Generally in younger samples, less than 40 years old, the association was positive, such that suicide 
attempts were associated with greater cortisol levels, but for older samples the effect was reversed, 
with suicide attempts associated with lower cortisol levels. Moreover, the moderating effects of age 
were also significant in studies that assessed cortisol in the morning and afternoon/evening. The 
relationship between cortisol and suicide attempts was not influenced by percentage of males in study 
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samples or year of publication. However, as frequently observed in meta-analyses, the study quality 
influenced the associations, such that, smaller effect sizes were observed in better quality studies.    
These findings indicate clearly that a reversal in the association between cortisol and suicidal 
attempt occurs when the average age of the sample is 40 years or older. This is not to imply that for 
any individual the shift would happen at 40 years, this is on average. Nonetheless, what these analyses 
do demonstrate is that for older people the association is negative and for younger people it is positive 
and that the relationship between cortisol and suicide attempts is more complex than previously 
acknowledged. In addition, these findings may have implications for research studies that have 
assessed HPA axis functioning using pharmacological manipulation of the stress system such as the 
DST and raise the interesting question as to whether age moderates the extent to which cortisol is 
suppressed following manipulation.  
What may account for this reversal of the association between cortisol levels and suicide 
attempts? The short answer is we do not know. We are mindful that there is huge variation in the 
studies, their designs and in cortisol and suicidal attempt assessments (see shortcomings section 
below). Nevertheless, with these caveats notwithstanding and the obvious associated “noise” linked to 
meta-analyses generally, we feel these findings are worthy of dissemination and may be important to 
inform future research. Therefore, within this context, we feel there are a number of plausible 
explanations that may account for the observed effects.  
Broadly speaking, the findings are consistent with McEwen’s notion of allostatic load, 
whereby if the HPA axis is repeatedly activated (by stress) the immune, cardiovascular and the 
endocrine systems are potentially exposed to excessive demands that over time can lead to 
dysregulation of these systems (McEwen, 1998; 2000). For example, a recent large scale prospective 
study, using a comprehensive measure of allostatic load (including cortisol levels), found that 
participants with higher allostatic load scores had a greater risk of having died 10 years later from all-
cause mortality (Hwang et al., 2014). Therefore, in the current context, naturally fluctuating cortisol 
levels may provide an index (or proxy) for the amount of stress exposure that individuals have 
encountered. This view is also consistent with an influential account of the development of 
hypocortisolism, which suggests that the latter phenomenon occurs after a prolonged period of 
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hyperactivity of the HPA axis due to chronic stress (see Fries et al., 2005) for detailed discussion of 
precise mechanisms). As such, younger individuals (less than 40 years), who have been exposed to 
serious stressful and psychosocial events, are likely to continue to exhibit an adaptive HPA axis stress 
response in the short to medium term (by releasing high levels of cortisol in response to their adverse 
and stressful environment). In contrast, in individuals who are older (40 years or older) and who have 
likely been exposed to stressful and traumatic events over a longer, more sustained period, their HPA 
axis may have become dysregulated leading to lower secretion of circulating cortisol levels. Indeed, 
lower circulating levels of cortisol have been observed in older Holocaust survivors with PTSD 
compared to those without PTSD (Yehuda et al., 1995). Furthermore, time course effects have also 
been found in studies of suicide attempters with major depressive disorders (MDD) (e.g., Ehnvall et 
al., 2004; Lindqvist et al., 2008). For example, Lindqvist et al. (2008) found that greater suicidal 
intent was associated with lower post DST cortisol levels. Indeed, these authors speculated that this 
finding reflected an association between the chronicity of the illness, high suicidal intent and a “worn-
out” HPA axis (p. 205), such that the prolonged depressive illness alters the HPA axis feedback 
system, moving it from a hyperactive state to a more normal like state (see also Ehnvall et al., 2004). 
Moreover, in the current meta-analysis, the differences in absolute cortisol levels between the groups 
support this theorizing with under 40 year olds who had attempted suicide exhibiting higher cortisol 
levels compared to under 40 year olds who had not attempted suicide. In contrast, over 40 year olds 
who had attempted suicide exhibited lower cortisol levels compared to over 40 year olds who had not 
attempted suicide.  
This possible explanation is also in keeping with the findings by Miller et al., 2007). In their 
review, Miller and colleagues highlighted the importance of the temporal features of stressors and 
showed that time of onset of stress was negatively associated with HPA axis activity. More 
specifically, they found that the greater the amount of time that had passed since the stressor was 
encountered, the lower participants’ morning cortisol and total daily cortisol output. These authors 
argued that the HPA axis exhibits initial activation in the form of elevated cortisol release (as 
observed in studies here with a mean age of less than 40 years). However, following prolonged 
exposure to the stressors, they theorized that, this activity reduces and cortisol secretion rebounds to 
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less than normal. As a result, it is possible that in individuals over 40 years old, that the more they fail 
to mount an appropriate cortisol response, the greater their suicide risk. For example, 
hyporesponsivity of the HPA axis to acute stressors (as well as hyperresponsivity) has been found to 
impair decision-making processes and emotional reactivity, aspects of cognitive functioning that are 
associated with suicidal behavior (Giletta et al., 2015; Jollant et al., 2011; Turecki et al., 2012; van 
Honk et al., 2003).  
As well as identifying the importance of age as a moderator of the cortisol and suicide attempt 
relationship, the results of this meta-analysis may help to clarify the mixed and inconsistent findings 
observed to date in this literature. Previous studies have shown that suicidal attempts are associated 
with elevated cortisol (or hypercortisolism) as well as blunted or low cortisol levels (or 
hypocortisolism) (e.g., Mann and Currier, 2007; Lindqvist et al., 2008). The current results reveal that 
both types of observations may be valid and true, but may be accounted for by age-dependent 
exposure to stress overtime. However, this meta-analysis does not shed any additional light on the 
relationship between HPA axis functioning and completed suicide (as distinct from suicide attempt). 
Existing evidence from prospective DST studies suggests that HPA hyperactivity is more consistently 
associated with completed suicide compared to suicide attempt (Mann and Currier, 2007). For 
example, Coryell and Schlesser (2001) reported that there was a 14 fold higher risk of completed 
suicide in DST non-suppressors compared to suppressors. In contrast, the evidence for a clear 
relationship between HPA hyperactivity, as assessed using the DST, and suicide attempt is mixed. 
Some studies have shown that DST suppression status is unable to distinguish between individuals 
who will attempt suicide and those who will not. Yet other research findings have demonstrated DST 
suppression is associated with a higher rate of suicide attempts (see Mann & Currier, 2007 for a 
review). Mann and Currier suggest that an important reason why non-suppression on the DST is 
predictive of completed suicide may be because it is also associated with “a failure to respond to 
antidepressant treatment or a tendency for early relapse such as shortly after discharge” (p. 10). 
Therefore, within this context, future research ought to attempt to synthesise existing prospective 
studies investigating the relationship between naturally fluctuating levels of cortisol and completed 
suicide and to examine the potential moderating role of age.   
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We recognize that there are a number of shortcomings and limitations of this meta-analysis 
that require further comment. There was a great deal of variability across the studies in terms of how 
suicide attempt was assessed, the timing and measurement of cortisol samples and in relation to 
controlling for confounding variables. As a result, conclusions about the precise nature of the 
relationship between cortisol and suicide attempt remain unknown. Therefore, future investigators 
ought to improve the quality of their studies in this area by utilising longitudinal designs (over many 
years) that incorporate assessments of suicidal behavior using clinical interviews or validated scales 
and ensure cortisol is sampled at numerous time points across the day (morning, afternoon, evening) 
over multiple days. In addition, it is incumbent on researchers to investigate why age moderates the 
relationship between fluctuating cortisol levels and suicide attempt and to explore the role played by 
different, traumatic and stressful psychosocial events (including psychiatric co-morbidities) within the 
context of allostatic load, PTSD, hypocortisolism and chronic stress models. We acknowledge also 
that the current meta-analysis did not include studies that utilised a pharmacological manipulation of 
cortisol levels and that approaches such as the DST have a number of important advantages over 
studies that have included one or more naturally occurring assessments of cortisol. We are cognizant 
that the former research designs allow for carefully controlled experimental investigation of how the 
HPA responds to challenge as well as permitting important variables such as time of day to be held 
constant. Nevertheless, given the DST and suicide literature has been successfully reviewed elsewhere 
(Jollant et al., 2011; Mann and Currier, 2007) and because of the concerns raised that the DST may 
not accurately mimic how the HPA axis responds to naturally occurring stressors (McGirr et al., 
2011), we were motivated to synthesis the existing studies that has been conducted outside the 
laboratory. Nevertheless, to our mind, in order to fully and accurately characterise how the HPA axis 
responds to stress in vulnerable individuals, future research ought to integrate pharmacological, 
laboratory-based stress challenges and naturally occurring approaches that assess the cortisol 
awakening response as well as cortisol levels throughout the day (see Gartland et al., 2014; O’Connor 
et al., 2009).  
In summary, these findings confirm that HPA axis activity, as indicated by age-dependent 
variations in cortisol levels, is associated with suicidal behavior. The challenge for theory and clinical 
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practice is to explain the complete reversal of the association with age and to identify its clinical 
implications.    
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Table 1. Study Characteristics  
Authors Year Mean 
Age 
(yrs) 
Sex 
(% 
male) 
Analytic 
Method 
Sample 
Time 
N Effect 
Size 
Diagnosis Time since 
attempt 
Type of control Quality 
score 
Ayuso-Gutiérrez 
et al. 
1987 55.8  14.08 Blood 
Plasma 
 
morning 117  -.031 Major 
Affective 
Disorder 
Unreported Non-attempters 6 
Brown et al. 1986 55.8 33.0 Blood 
Plasma 
morning 64  -.165 MDD Recent 
suicide 
attempt ≤ 4 
weeks ago; 
past suicide 
attempt > 4 
weeks ago 
(groups 
collapsed) 
Non-attempters 7 
afternoon  57  -.292 
 
    
Brunner et al.  2002 38.33 23.97 Blood 
Plasma 
 
morning 28  .190 Depressive 
spectrum 
disorder 
5 – 23 days, 
mean time 
interval: 16 
days 
Depressed non-
attempters & 
neurological 
controls 
3 
Brunner et al. 2001 35.35 50.75 Blood 
Plasma 
 
morning 34  .080 Mixed  Shortly before 
admission 
Non-suicidal 
psychiatric 
patients & 
neurological 
controls 
2 
Chatzittofis et al.
 
 2013 37 63.73 Blood 
Plasma 
 
morning 43  .305 Mixed; 
50% 
depressive 
disorder 
“recent 
suicide 
attempt”; 
time-frame 
Healthy controls 9 
23 
 
unreported 
Gmitrowicz & 
Kolodziej-
Maciejewska 
2002 17.62 63 Blood 
Serum 
 
morning 114  .060 Mixed  
Prior to 
hospitalisatio
n; 
biochemical 
tests carried 
out 2-6 days 
after 
admission 
 
Non-attempters 8 
Inder et al. 1997 32.5 54.43 Blood 
Plasma 
 
afternoon 56  .185 Unipolar 
depression 
Within 1 
month 
Depressed non-
attempters  
5 
Jokinen et al.
 
2010 47  37.25 Blood 
Plasma 
 
morning 50  -.343 Mood 
disorder 
Patients had 
attempted 
suicide just 
before the 
admission; 
71% had 
biological 
tests within 8 
days of 
admission 
Non-attempters 7 
Kamali et al.  2012 38.95 32.33 Saliva morning 165  -0.73 Bipolar 
spectrum 
Unreported Bipolar non-
attempters & 
healthy controls 
11 
evening 164  .174 
 
    
Karlovic et al. 2012 47.55 63.64 Blood 
Serum 
 
morning 55  -.057 MDD Unreported MDD non-
attempters 
7 
24 
 
Kelip et al. 2010 43.3 54.76 Blood  
 
morning 53  -.131 Depression Unreported Non-attempter 
patients & 
healthy controls 
8 
Kim et al.  2013 43.76 0 Blood 
 
n/a 359 -.091 MDD Within 1 
month 
Non-attempters 6 
Lindqvist et al.  2008 48.95 39.91 Saliva morning 51  -.167 Mixed  Unreported Non-attempters 11 
afternoon 51  -.181     
evening 51  -.276 
 
    
Marcinko et al. 2005 26.47 100 Blood 
Serum 
 
morning 46  .583 Schizophre
nia 
Soon after 
admission, 
exact duration 
unreported 
Non-attempters 6 
Markianos et al.  2009 37.6 100 Blood 
Plasma 
 
morning 73  .258 Mixed  Within 1 
week 
Accident 
patients & 
healthy controls 
5 
McGirr et al. 2011 42.01 37.16 Blood 
Plasma 
 
morning 148  -.244 Mixed  Unreported Non-attempters 8 
Ostroff et al. 1982 32.0 100 Urine 
 
24 hour 21 .144 Mixed  Prospective; 
Last cortisol 
sample 1-3 
weeks prior 
attempt 
Non-attempters 8 
Pitchot et al. 2005 40.66 60 Blood 
Plasma 
 
morning 60  -.166 Major 
depression 
Unreported Non-attempters 10 
25 
 
Pitchot et al.  1995 39.7 69.70 Blood 
Plasma 
 
morning 66  -.160 Unipolar 
depression 
Within 
current 
episode of 
depression 
Non-attempters 9 
Plocka-
Lewansdowska et 
al.  
2001 38 65.63 Blood 
Plasma 
 
afternoon 32  .368 Schizophre
nia 
Unreported Non-attempters 4 
Roy  1992 44.2 22.22 Blood 
Plasma 
 
afternoon  44  -.015 Major 
depressive 
episode 
Unreported Non-attempters 6 
Saiz et al.  1997 31.72 17.19 Blood 
 
morning 256  .188 Unreported Minimum of 
3 months 
after an 
attempt 
Non-attempters 7 
Secunda et al. 1986 44.95 49.67 Blood 
Plasma 
morning 80  -.224 MDD Mean 
duration 34.2 
weeks 
Non-attempters 8 
evening 73  -.069 
 
    
Traskman et al. 1980 46.33 - CSF 
 
morning 61  .143 Mixed  Unreported Depressed non-
attempters 
6 
Tripodianakis et 
al.  
2000 26.25 35.38  Blood 
Plasma 
 
morning 103  .365 Adjustment 
disorder 
24 hours Non-attempters 8 
Van Heeringen et 
al.  
2000 35.45 75.96 Urine 
 
24 hour 40  .375 Unreported 8 cases prior 
to the current 
admission, 9 
historical 
suicide 
Non-suicidal 
psychiatric 
controls 
6 
26 
 
attempt 
Westrin et al. 1999 37 38.88 Blood 
Serum  
afternoon 72 .452 Depressive 
disorder 
Inpatients: 
Mean 14 days 
(Range 5 -42 
days). 
Outpatient: 3 
months 
Non-attempters 10 
Note. In some studies the N for AM and PM assessments on the same samples vary. In all the meta-analysis where AM and PM were combined for these 
studies the average r and mean age (rounded down if there was a decimal) were entered into the specific analyses. When AM and PM are assessed separately 
the actual AM and PM Ns were used. 
Note: MDD = Major Depressive Disorder; Mixed = Mixed psychopathology 
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Table 2. Meta-analysis results 
 Basic Stats Publication Bias Moderation 
 k r 95% (CI) p I
2
 Egger’s 
Intercept 
Trim and Fill 
Adjusted 
Moderation by 
Age 
(Regression) 
Moderation by 
sex (ANOVA) 
Overall (all) 27 .071 -.02, .16 .132 79.56 1.47, p = .24 -.002 (4 to the left) -0.015, p < .001 p = .058 
Overall (AM & PM) 24 .066 -.03, .16 .201 79.96 0.60  p  = 71 .066 (no adjustment) -0.014, p <.001 P = .145 
AM 20 .027 -.08,  .132 .621 78.53 -0.28, p = .87 .027 (no adjustment) -0.013, p <.001 P = .456 
PM 8 .065 -.13, .26 .517 82.95 -0.25, p = .95 .065 (no adjustment) -0.027, p < .001 P = .129 
          
 Moderation by Age 
 k r 95% (CI) p  Q    
< 40 (all) 15 .234 .135, .329 < .001  34.5, p < .001    
≥ 40 (all) 12 -.129 -.194, -.063 = .004      
          
< 40 (AM + PM) 13 .229 .121, .332 < .001  28.33. p < .001    
≥ 40 (AM + PM) 11 -.137 -.214, -.059 = .001      
          
< 40 (AM) 10 .184 .046, .315 = .009  15.12, p < .001    
≥ 40 (AM) 10 -.136 -.215, -.055 = .001      
          
< 40 (PM) 4 .287 .131, .429 < .001  21.96, p < .001    
≥ 40 (PM) 4 -.186 -.279, -.070 = .002      
AM = early morning and before 12pm, PM = after 12pm. Three studies reported no time or utilised 24 hr assessments (Kim et al., 2013; Ostroff et al., 1982; van Heeringen et 
al., 2000). These were included in the analyses of all samples (all), but excluded from AM and PM analyses, therefore AM + PM has an N of 24 studies 
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Figure 1: Summary of moderating effects of age 
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Supplementary Materials 
Figure 1: PRISMA 2009 Flow Diagram 
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Additional records identified through 
other sources  
(n = 0) 
Records after duplicates removed  
(n = 491) 
Records screened: Abstract 
& Title (n = 491) 
Records excluded  
(n = 365) 
Full-text articles assessed for 
eligibility  
(n = 126) 
Full-text articles (n = 99) 
Main reasons for exclusion: 
(1) not an original research 
study published in a peer-
reviewed journal, (2) not 
reporting naturally occurring 
cortisol levels, prior to any 
manipulation (3) no measure 
or indication of suicide 
attempt history, (4) no case 
comparison of suicide 
attempters to non-
attempters. 
 
 
Studies included in meta-
analysis  
(n = 27) 
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Supplementary Materials 
Figure 2: Meta-regression of the mean age on Fisher’s Z (k = 27) 
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Supplementary Materials 
Figure 3. Forest plot of the observed association between suicide attempt and cortisol when studies were grouped by categorical age (n=27)
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 Rated based on what cortisol data was included in the analysis 
 
 
 
Supplementary Table 1. Quality assessment tool and scoring guide  
Score  
Criteria 
0 1 2 3 
Design Cross-sectional  
Groups not adequately 
matched.   
Cross-sectional            
Minimum age and 
gender matched. 
Longitudinal.          
Requires details of follow-up procedure. 
 
Sample Size 
Median sample size 56 
Total sample < 56.  Total sample >56 but 
unequal group sizes (if 
applicable).  
Total sample >56 participants, 
approximately equal group sizes (if 
applicable).  
 
Suicide Assessment No mention of how 
suicide attempt history 
was assessed.    
Non-validated scale or 
other means of self-
report (e.g. single 
question) 
Hospital admission where intent has not 
been established; suicide items from a 
validated diagnostic/ mood rating scale 
(e.g. HDRS, BDI, SADS).  
Clinical interview; validated suicide scale 
(e.g. SIS, SAS); hospital admission where 
intent has been established; death 
certificate/cause of death register 
Cortisol Assessment
1
 
(Frequency) 
Cortisol sampled at one 
time point.  
e.g. morning  
 
Cortisol sampled at two 
or more time points, on 
one day.  
e.g. morning and 
evening 
Cortisol sampled over multiple days.    
Psychiatric Assessment No mention of how 
diagnosis was established.  
Validated scale (e.g. 
HDRS, MADRS, BDI) 
Clinical/diagnostic interview (e.g. SCID-I; 
SCID-II; SADS)  
 
Confounding variables  
To what extent has there 
been an attempt to 
account for confounding 
variables
 
  
No attempt to account for 
potential confounding 
variables in recruitment or 
analysis.  
Accounts for basic 
confounding variables 
either during recruitment 
or analysis  
E.g. Age, Gender 
Accounts for additional confounding 
variables either during recruitment or 
analysis. 
E.g. Substance abuse, physical illness, 
childhood trauma, medication   
 
